Immix Biopharma, Inc. IMMX Operating Lease Liability Payments - 2026 (Lessee)
Operating Lease Liability Payments - 2026 (Lessee) at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s operating lease liability payments - 2026 (lessee).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s operating lease liability payments - 2026 (lessee)?
- Immix Biopharma, Inc. (IMMX) reported operating lease liability payments - 2026 (lessee) of $169.6K in Q1 2026.
- How has Immix Biopharma, Inc.'s operating lease liability payments - 2026 (lessee) changed year-over-year?
- Immix Biopharma, Inc.'s operating lease liability payments - 2026 (lessee) increased by 3.5% year-over-year, from $163.87K to $169.6K.
- What does operating lease liability payments - 2026 (lessee) mean?
- This represents the specific cash outflow commitment for operating leases scheduled for the calendar year 2026. It allows investors to isolate the impact of real estate and equipment lease obligations on the company's cash flow in a specific future period.